Loading...
Atlantic International Corp.
ATLN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$1.75
$-0.02(-1.13%)
Atlantic International Corp. (ATLN) Financial Performance & Income Statement Overview
Review Atlantic International Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.27%
↑ 10.27%
Operating Income Growth
-532.61%
↓ 532.61%
Net Income Growth
-788.28%
↓ 788.28%
Operating Cash Flow Growth
34.10%
↑ 34.10%
Operating Margin
-6.78%
↓ 6.78%
Gross Margin
10.49%
↑ 10.49%
Net Profit Margin
-31.78%
↓ 31.78%
ROE
-4296.31%
↓ 4296.31%
ROIC
274.98%
↑ 274.98%
Atlantic International Corp. (ATLN) Income Statement & Financial Overview
Review Atlantic International Corp.'s (ATLN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $129.55M | $107.80M | $104.64M | $0.00 |
| Cost of Revenue | $116.21M | $95.92M | $94.40M | $41329.00 |
| Gross Profit | $13.34M | $11.89M | $10.24M | -$41329.00 |
| Gross Profit Ratio | $0.10 | $0.11 | $0.10 | |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $316263.00 |
| SG&A Expenses | $17.98M | $17.15M | $18.55M | $708229.00 |
| Operating Expenses | $19.21M | $18.40M | $18.55M | $1.02M |
| Total Costs & Expenses | $135.42M | $114.32M | $112.95M | $1.07M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.51M | $1.47M | $4.000M | $39820.00 |
| Depreciation & Amortization | $1.24M | $1.25M | $1.25M | $41329.00 |
| EBITDA | -$40.79M | -$5.55M | -$66.88M | -$1.01M |
| EBITDA Ratio | -$0.31 | -$0.05 | -$0.64 | |
| Operating Income | -$5.88M | -$6.51M | -$8.31M | -$1.07M |
| Operating Income Ratio | -$0.05 | -$0.06 | -$0.08 | |
| Other Income/Expenses (Net) | -$37.66M | -$1.76M | -$63.82M | -$29759.00 |
| Income Before Tax | -$43.54M | -$8.27M | -$72.13M | -$1.10M |
| Income Before Tax Ratio | -$0.34 | -$0.08 | -$0.69 | |
| Income Tax Expense | $25.11M | -$1.22M | -$17.22M | $2.00 |
| Net Income | -$68.65M | -$7.05M | -$54.91M | -$1.10M |
| Net Income Ratio | -$0.53 | -$0.07 | -$0.52 | |
| EPS | -$61.45 | -$6.31 | -$73.25 | -$2.87 |
| Diluted EPS | -$61.45 | -$6.31 | -$1.96 | -$2.87 |
| Weighted Avg Shares Outstanding | $1.12M | $1.12M | $749686.00 | $382151.00 |
| Weighted Avg Shares Outstanding (Diluted) | $1.12M | $1.12M | $749686.00 | $382151.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan